Status BTA Rapid Bladder Tumor Test, CLIA Waived, Qualitative Detection of Bladder Tumor Associated Antigen, 25 Tests/Box
The Status BTA Rapid Bladder Tumor Test is a CLIA-waived, in vitro diagnostic immunoassay for the qualitative detection of bladder tumor associated antigen in urine. It provides rapid results to aid in the monitoring and management of patients with bladder cancer. Each box contains 25 test devices for convenient clinical use.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
The Status BTA Rapid Bladder Tumor Test is a CLIA-waived, in vitro diagnostic immunoassay for the qualitative detection of bladder tumor associated antigen in urine. It provides rapid results to aid in the monitoring and management of patients with bladder cancer. Each box contains 25 test devices for convenient clinical use.
1 vendor
.png&w=3840&q=85)
